Nanotech

NanoXplore Inc. ("NanoXplore" or the "Company") ( TSX: GRA and OTCQX: NNXPF ), a world-leading graphene company, announced today that it has acquired all of the issued and outstanding shares of Canuck Compounders Inc. ("Canuck") for a total cash consideration of approximately $9.3 million subject to post-closing adjustments, which represents a multiple of approximately five times of the average EBITDA (1) of the last three years.

Canuck, a privately held plastic recycling compounder for the past 30 years, provides sustainable and engineered recycled plastic compounds for use in transportation, building and construction, agriculture and packaging markets. Canuck's manufacturing facility, based in Cambridge, Ontario, has a production capacity of approximately 40 million pounds annually.

"I am very pleased with this acquisition and would like to welcome Canuck's team to the NanoXplore family," said Dr. Soroush Nazarpour, Chief Executive Officer of NanoXplore. "This acquisition is strategically aligned with our growth initiatives and significantly increases our graphene compounding capability, especially in recycled plastics and will enable us to form strategic partnerships with end customers. In addition, Canuck has a strong relationship with recycled plastic suppliers that ensures a smooth and reliable supply of post-consumer and post-industrial recycled plastics. This transaction will enhance our technical expertise in recycled plastic compounds and bolster our top-line by approximately $20 million annually, without considering revenues derived from graphene inclusion."

NanoXplore paid $7.3 million in cash at the closing of the transaction, while $1 million in cash will be paid in one year and another $1 million will be paid in two years. Following the transaction, William Dickinson, CEO and founder of Canuck, will continue in a role as General Manager, alongside approximately 40 employees.

"We are delighted to join forces with NanoXplore, given the inherent technological and cultural fit between the two companies," Mr. Dickinson said. "Graphene from NanoXplore is highly complementary with our recycled plastic compounds to create innovative solutions like enhanced masterbatch and mixtures, while both management teams are dedicated to delivering best-in-class products across a broad number of growth industries."

As demonstrated by the Canuck acquisition, NanoXplore is seeking to expand its downstream, value-added product offering through enhanced masterbatch and compounds, Anode and Cathode pastes, battery materials for the Li-ion battery market, formulated thermoset resins, and admixtures for cement.

"This expansion of activities positions NanoXplore, not only as a world-leading graphene company, but also as a provider of graphene-enhanced, ready-to-use solutions," Dr. Nazarpour added. "Such value-added formulations support the Company's profitability in the long term and provides a competitive advantage over other graphene producers in the future. We anticipate that such expansion of activities will be carried out through a combination of acquisitions and partnerships."

Financial Guidance

"For fiscal 2022 ending June 30, 2022, we expect annual revenues of about $85 million," said Luc Veilleux, Chief Financial Officer of NanoXplore. "We anticipate that revenues in the second quarter will be in-line with the first quarter of fiscal 2022, followed by progressive growth in the third and fourth quarters due to the Canuck acquisition and improved outlook provided by customers . We also expect to achieve positive EBITDA (1) in the fourth quarter of 2022."

About NanoXplore

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities in Canada, the United States and Europe.

Forward-looking Statements

This press release contains forward-looking statements, including but not limited to statements related to expected future revenues and expected EBITDA. All forward-looking statements are based on our beliefs as well as assumptions based on information available at the time the assumption was made and on management's experience and perception of historical trends, current conditions and expected future developments, as well as other factors deemed appropriate in the circumstances. No assurance can be given that these assumptions and expectations will prove to be correct. Forward-looking statements are not facts, but only predications and can generally be identified by the use of statements that include phrases such as "anticipate", "believe", "continue", "could", "estimate", "foresee", "grow", "expect", "plan", "intend", "forecast", "future", "guidance", "may", "predict", "project", "should", "strategy", "target", "will" or similar expressions suggesting future outcomes .

Forward-looking information is not a guarantee of future performance and involves a number of risks and uncertainties. Such forward-looking information necessarily involves known and unknown risks and uncertainties, (including some of the factors discussed in the Company's Annual Information Form and other public filings for its most recent financial year end which can be found at www.sedar.com) which may cause NanoXplore's actual results to differ materially from any projections of future results expressed or implied by such forward-looking information. Any forward-looking information is made as of the date hereof and, except as required by law, NanoXplore does not undertake any obligation to publicly update or revise such information to reflect new information, subsequent or otherwise.

(1) Non-IFRS Measures

EBITDA means net earnings (loss) before interest expenses, income taxes, depreciation and amortization. We use EBITDA because we believe it is a meaningful measure of the operating performance of our ongoing business without the effects of certain expenses. The definition of this non-IFRS measure used by the Company may differ from that used by other companies.

For more information, please contact:

Soroush Nazarpour
President & CEO
NanoXplore Inc.
info@NanoXplore.ca
(514) 935-1377


News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF

NanoXplore Reports Improved Third-Quarter 2022 Financial Results

NanoXplore Inc. ("NanoXplore" or "the Company") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the third quarter ended March 31, 2022.

HIGHLIGHTS

Keep reading... Show less

NanoXplore and Molding Products Execute Long Term Supply Agreement for GrapheneBlack Enhanced Composite Materials for Transportation Market

NanoXplore Inc. (" NanoXplore " or the " Corporation ") (TSX: GRA and OTCQX: NNXPF) announces that it has entered into a long-term supply agreement with Molding Products LLC to produce and sell graphene-enhanced Sheet Molding Compound ("SMC") called GrapheneBlack™ SMC, used to create high quality, lightweight composite exterior and battery enclosure parts for cars and trucks, such as hoods, bumpers, roofs, and battery packs. GrapheneBlack™ SMC delivers weight reduction of up to 15% vs typical composite parts while also improving surface finish, paintability, and crack resistance. Under the terms of the agreement, both companies can market and sell the new premium grade of SMC under the NanoXplore tradename. Weight reduction is becoming increasingly important for the transportation industry, particularly because electric vehicles are generally heavier than internal combustion engine vehicles and range anxiety could be addressed by reducing the weight of the vehicles. Furthermore, lightweight sheet molding composites are being used increasingly in electric vehicle battery packs that would be complementary to NanoXplore battery related activities.

The agreement with NanoXplore secures a competitive, localized supply of high-quality graphene to produce GrapheneBlack™ SMC as well as R&D support for the development of new graphene-enhanced product grades. NanoXplore is the world's largest manufacturer of sustainable, high-quality, cost-effective graphene with 4,000 metric tons of annual production capacity in Montreal, Canada.

Keep reading... Show less

NanoXplore Inc. to Announce Third Quarter Results Conference Call on Tuesday May 17, 2022, and the Nomination of its Director of Investor Relations

NanoXplore Inc. (TSX: GRA and OTCQX: NNXPF) ("NanoXplore") is pleased to hold a conference call to discuss the results of its third quarter ended March 31, 2022, on Tuesday, May 17, 2022, at 8:30 a.m. Eastern Time. The financial results will be released on Monday, May 16, 2022, after the market close.

Details of the Q3 Conference Call

Keep reading... Show less

Solmax and NanoXplore formalize their relationship after five years of collaboration and innovation through a blanket purchase order

NanoXplore Inc. (" NanoXplore ") (TSX: GRA and OTCQX: NNXPF) and Solmax Group Inc. (" Solmax ") announce that they entered into a blanket purchase order, result of several years of collaborative work.

The five-year collaboration between the two companies has resulted in a product that is the first of its kind in the environmental infrastructure market. "This cooperation underscores our commitment to delivering growth through forward-looking innovation and collaboration," says Solmax CEO, Jean-Louis Vangeluwe. "Our five-year development collaboration with NanoXplore will allow us to launch a next-generation product based on graphene technology that solves some of our customers' sustainability challenges while also boosting performance."

Keep reading... Show less
Nirvana Life Sciences Inc.

Nirvana Life Sciences Inc.

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Latest Press Releases

Related News

×